NASDAQ: GPCRStructure Therapeutics Inc Stock Ownership - Who owns Structure Therapeutics?
Insider buying vs selling
Have Structure Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when GPCR insiders and whales buy or sell their stock.
GPCR Shareholders
What type of owners hold Structure Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Wellington Management Group LLP | 4.51% | 7,791,183 | $168.91M | Institution |
| Fil Ltd | 3.75% | 6,473,761 | $140.35M | Insider |
| Fmr LLC | 3.41% | 5,883,707 | $127.56M | Institution |
| Fmr LLC | 3.10% | 5,345,338 | $115.89M | Insider |
| Janus Henderson Group PLC | 2.52% | 4,355,194 | $94.42M | Institution |
| Deep Track Capital LP | 2.38% | 4,100,000 | $88.89M | Institution |
| Ramy Farid | 1.89% | 3,260,495 | $70.69M | Insider |
| Jun Yoon | 1.65% | 2,847,885 | $61.74M | Insider |
| Raymond C. Stevens | 1.56% | 2,688,264 | $58.28M | Insider |
| Capital Research Global Investors | 1.25% | 2,164,145 | $46.92M | Institution |
GPCR vs Biotech Stocks
Structure Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.